Aurora Cannabis Sees Q4 Growth In Medical Cannabis While Consumer Segment Declines Materially

Aurora Cannabis (TSX: ACB) saw revenue of $67.4 million in its fiscal fourth quarter on a net basis. The topline figure grew by 5% on a year over year basis, which the company largely attributes to strong growth in its global medical cannabis business, which saw growth of 20%.

The firms fiscal year 2023 notably consisted of only three quarters as a result of modifying the fiscal year. The results are for the period ended March 31, 2024.

Revenue during the quarter was largely attributable to the medical segment, which posted 20% growth year over year, ending the quarter at $45.6 million. Consumer cannabis meanwhile declined by 29%, falling to $10.2 million. Plant propagation fell by a less dramatic 3%, to produce revenues of $10.4 million during the quarter.

A total of 15,179 kilograms of cannabis were sold during the period, an 8% decline year over year, while the average net price of cannabis, excluding bulk sales, improved 13% to $5.37 per gram.

READ: Aurora Cannabis Replaces CFO, Conducts Reverse Split

Selling, general and administrative expenses for the quarter amounted to $31.6 million on an adjusted basis, which excludes $8.0 million in restructuring and non-recurring costs. Net loss for the period overall amounted to $20.8 million, whiled Adjusted EBITDA came in at $1.9 million.

In terms of the firms balance sheet, a final $7.2 million payment was made on a convertible senior note, resulting in the company now being debt free. Aurora’s cash position meanwhile sits at $180 million.

In terms of outlook, the company is calling for mid-to-high teens growth in net revenue on a percentage basis in the first quarter of fiscal 2025, while positive adjusted EBITDA should also be higher, along with operating cash flow.

Aurora Cannabis last traded at $7.73 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

PI Financial Lowers Price Target on Aurora Cannabis

Aurora Cannabis (TSX: ACB) (NYSE: ACB) saw PI Financial lower its price target today after...

Thursday, September 12, 2019, 06:03:52 PM

Aurora Cannabis Closes US$172.5 Million Financing

Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning announced the closing of its overnight marketed...

Monday, November 16, 2020, 10:09:41 AM

Battley Leaves Executive Role at Aurora Cannabis

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has seen its chief corporate officer Cam Battley step...

Saturday, December 21, 2019, 05:46:13 PM

Galaxy Brain: Aurora Charting a Course through the Cannabis Supply Glut

For this weekend’s special piece, Deep Dive author Matthew Cox breaks down the Health Canada...

Saturday, November 23, 2019, 08:36:04 AM

Aurora Cannabis Posts Loss of $158 Million for Third Quarter

Aurora Cannabis (TSX: ACB; NYSE: ACB) reported its third quarter 2019 earnings last night, posting...

Wednesday, May 15, 2019, 07:00:27 AM